The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Kintegral Advisory LLC

Kintegral Advisory LLC reduced its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 32.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,923 shares of the medical device company's stock after selling 3,887 shares during the period. Kintegral Advisory LLC's holdings in Cooper Companies were worth $668,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Cooper Companies by 15.1% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company's stock worth $2,194,000 after buying an additional 3,440 shares in the last quarter. State of Alaska Department of Revenue boosted its holdings in Cooper Companies by 3.0% during the first quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company's stock worth $1,972,000 after buying an additional 680 shares in the last quarter. DAVENPORT & Co LLC boosted its holdings in Cooper Companies by 13.4% during the first quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company's stock worth $366,000 after buying an additional 513 shares in the last quarter. Proficio Capital Partners LLC purchased a new stake in Cooper Companies during the fourth quarter worth $95,000. Finally, Steward Partners Investment Advisory LLC boosted its holdings in Cooper Companies by 19.1% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 1,407 shares of the medical device company's stock worth $129,000 after buying an additional 226 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

COO has been the topic of a number of recent analyst reports. Needham & Company LLC raised shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price target on the stock in a report on Tuesday, June 17th. Wall Street Zen upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Loop Capital set a $100.00 price objective on shares of Cooper Companies in a report on Tuesday, June 17th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $76.00 price objective (down from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Finally, Wells Fargo & Company decreased their price objective on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a report on Friday, May 30th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat.com, Cooper Companies currently has a consensus rating of "Moderate Buy" and a consensus price target of $99.70.

Cooper Companies Price Performance

Shares of NASDAQ COO traded up $0.97 during mid-day trading on Tuesday, reaching $74.26. The company's stock had a trading volume of 2,786,074 shares, compared to its average volume of 1,726,386. The stock has a 50-day moving average of $75.29 and a two-hundred day moving average of $83.00. The stock has a market capitalization of $14.85 billion, a P/E ratio of 36.05, a P/E/G ratio of 1.79 and a beta of 0.99. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The Cooper Companies, Inc. has a 1-year low of $65.00 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The firm had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. During the same period last year, the business earned $0.85 earnings per share. Cooper Companies's revenue was up 6.3% compared to the same quarter last year. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.